Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)

This study has been completed.
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Emergent BioSolutions Identifier:
First received: February 13, 2009
Last updated: November 21, 2012
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2010
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: November 20, 2012